We are live on ! Find out more
TCRT icon

Alaunos Therapeutics

162 hedge funds and large institutions have $194M invested in Alaunos Therapeutics in 2021 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 62 increasing their positions, 31 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

855% more call options, than puts

Call options by funds: $16.9M | Put options by funds: $1.77M

100% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 31

42% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 19

5% more funds holding

Funds holding: 155162 (+7)

0.02% less ownership

Funds ownership: 0.35%0.33% (-0.02%)

35% less capital invested

Capital invested by funds: $297M → $194M (-$103M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
162
Holders Change
+7
Holders Change %
+4.52%
% of All Funds
2.84%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
27
Increased
62
Reduced
31
Closed
19
Calls
$16.9M
Puts
$1.77M
Net Calls
+$15.1M
Net Calls Change
+$14.5M
Name Holding Trade Value Shares
Change
Change in
Stake
Citadel Advisors
76
Citadel Advisors
Florida
$118K -$369K -1,205 -74%
VF
77
Virtu Financial
New York
$108K +$121K +397 New
ASRS
78
Arizona State Retirement System
Arizona
$107K +$917 +3 +0.8%
SPC
79
Sigma Planning Corp
Michigan
$101K +$113K +369 New
SPIA
80
Steward Partners Investment Advisory
New York
$99K +$27.2K +89 +33%
ACM
81
Allred Capital Management
Texas
$96K +$42.8K +140 +66%
HighTower Advisors
82
HighTower Advisors
Illinois
$95K +$917 +3 +0.9%
AWM
83
Act Wealth Management
Texas
$91K
WG
84
Welch Group
Alabama
$87K
CCP
85
Corient Capital Partners
California
$85K
CIBC Private Wealth Group
86
CIBC Private Wealth Group
Georgia
$75K +$917 +3 +1%
Public Employees Retirement Association of Colorado
87
Public Employees Retirement Association of Colorado
Colorado
$72K
BNP Paribas Financial Markets
88
BNP Paribas Financial Markets
France
$70.6K +$60.6K +198 +325%
AB
89
Amalgamated Bank
New York
$69K -$3.06K -10 -4%
TSS
90
Two Sigma Securities
New York
$64K +$72.2K +236 New
Teacher Retirement System of Texas
91
Teacher Retirement System of Texas
Texas
$63K +$12.8K +42 +22%
BRWA
92
B. Riley Wealth Advisors
Florida
$62K
HKAM
93
Horizon Kinetics Asset Management
New York
$62K
SWM
94
Sugarloaf Wealth Management
Georgia
$62K
Zurich Cantonal Bank
95
Zurich Cantonal Bank
Switzerland
$60K
GJIC
96
Gamble Jones Investment Counsel
California
$56K
SIG
97
Sargent Investment Group
Maryland
$55K
MLICM
98
Metropolitan Life Insurance Company (MetLife)
New York
$54.4K -$59.6K -195 -49%
Victory Capital Management
99
Victory Capital Management
Texas
$51K +$1.22K +4 +2%
Macquarie Group
100
Macquarie Group
Australia
$51K +$44.3K +145 +345%

TCRT Hedge Fund Activity: Q3 2021 in Review

162 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Alaunos Therapeutics (TCRT) for Q3 2021, worth a combined $194M — down 35% from $297M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new TCRT positions and 19 closed out — a net gain of 8 holders — while 62 added to existing stakes and 31 trimmed.

The largest buyer was Avidity Partners Management, opening a new position worth an estimated $6.12M. The largest seller was Miller Value Partners, exiting entirely with an estimated $27.2M sold.

  • 162 institutional investors held Alaunos Therapeutics (TCRT) as of Q3 2021, up from 155 in Q2 2021.
  • Funds reported $194M of Alaunos Therapeutics stock for Q3 2021, down 35% quarter-over-quarter.
  • 27 funds opened new Alaunos Therapeutics positions in Q3 2021 and 19 closed out, a net change of +8 holders.
  • The largest Alaunos Therapeutics buyer in Q3 2021 was Avidity Partners Management, an estimated $6.12M added.
  • The largest Alaunos Therapeutics seller in Q3 2021 was Miller Value Partners, an estimated $27.2M sold.

Based on aggregated 13F filings for Q3 2021.